Health
Amylyx experimental drug cuts serious blood sugar events in Phase 3
A Phase 3 trial tested the drug in people with post-bariatric hypoglycemia.
Written by AI1 source1 min
Loading…
Diagnostics, prosthetics, vaccines, genomics: the medicine that adds years to a life.
Medicine that wins years of life: AI-assisted screening examining millions of patients, next-generation vaccines, genomics moving from sequencing to treatment, prosthetics and implants restoring lost abilities. The section follows completed clinical trials, market authorisations, hospital roll-outs — the moment a technology stops being a paper and becomes care.
The numbers rule: cohorts, detection rates, avoided mortality, costs. We gladly cover the health systems deploying at scale — India, Brazil, Southeast Asia — because frugal technologies often prove themselves there before arriving anywhere else. Every article rests on the trial, authorisation or study behind it, and cites them.
A Phase 3 trial tested the drug in people with post-bariatric hypoglycemia.
College students reported less distress after five weeks of emotion-regulation training.
Princeton researchers found music activated brain networks for imagination and meaning.
L-BAIBA helps muscles adapt to exercise and improve their endurance.
About 5% of clear cell ovarian cancers showed high IL-17 activity.
Robotic CABG avoids cutting the breastbone, using small incisions between the ribs.
UCLA’s FLIMPSR reconstructs tissue images from scans with five times lower spatial resolution.
A study of 787 patients identifies tumor removal and treatment timing as survival factors.
ULTRA creates 3D virtual histology of glioma tissue in about 30 minutes.
A mouse study identifies TLR2 as a hub linking inflammation to heart repair.
In preclinical studies, a flexible implant read movement, sensation and organ signals.
Otp helps control stress, thyroid hormones and energy balance in adult mice.
Berkeley Lab scientists linked Huntington’s symptoms to widespread DNA breaks in mouse neurons.
MIT researchers found reusable prefrontal circuits in mice that store different kinds of memories.
Nearly half of patients on 15 mg reached 80% scalp coverage by week 24.
A JN.1-adapted booster improved antibody binding and neutralization.
LTG-001 reduced postsurgical pain more than placebo over 48 hours.
Researchers steered a tiny magnetic screw robot through sheep brain tissue in lab tests.